ArticleJournal of foot and ankle research2025
Exploring Patient and Podiatrist Perspectives of the 'In-Remission' Status in Diabetes-Related Foot Disease.
Article in Journal of foot and ankle research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Diabetic foot care: full-lifecycle management driven by digital intelligent technologies].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026Pooled it
- Three-Year Recurrence in People With Diabetic Foot Ulcers and Chronic Limb Threatening Ischemia Is Comparable to Cancer.International wound journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe term 'in-remission' has been historically associated with the disease status in cancer. In diabetes foot care, the term was introduced into risk stratification systems in order to support patient communication and healthcare prevention strategies post-ulceration. However, despite the inclusion of an 'in-remission' category into risk stratification systems, the adoption and perception of the terminology in clinical practice remains unknown. The aim of this study is to explore patient and clinician perceptions of the term 'in-remission' in the context of diabetes foot disease management.
methodsSemi-structured focus groups or interviews were conducted to identify the perceptions and impact of the term 'in-remission' on end users. Participants included patients classified as 'in-remission' as well as podiatrists who routinely work with people who have diabetes. Recruitment occurred via social media adverts, posters and snowball sampling. All focus groups and interviews were recorded and transcribed verbatim. Data were analysed for themes.
resultsThe study included n = 9 people with diabetes classified as in-remission and n = 12 podiatrists. One online focus group was held with n = 5 podiatrists, whereas individual telephone interviews were conducted with the remaining n = 7 podiatrists and all n = 9 participants with diabetes. Three overarching themes were identified with several sub-themes in each group. Perceptions and implementation of the term 'in-remission' were highly variable whereby podiatrists tend to avoid using the term directly with patients and instead focus on patient education and held mixed views of the impact on patients. People with diabetes were largely unaware of their 'in-remission' status and had varied opinions on what 'in-remission' means and how it may impact on foot care.
conclusionAwareness and implementation of the term 'in-remission' into podiatry practice are inconsistent. Despite the intention of the term to increase patient awareness and access to services, themes were identified regarding applicability and suitability resulting in avoidance by clinicians and confusion and fear from people with diabetes. These findings suggest that the term is not having the intended effect and further work is required to more fully explore the adoption of this terminology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.